A cross-sectional national questionnaire survey assessing the clinical attitudes of members of the British Menopause Society to the management of women with premature ovarian insufficiency

Post Reproductive Health

Volumn 20, Issue 3, 2014, Pages 90-97

  Mittal, Monica ^a   Savvas, Michael ^a   Narvekar, Nitish ^a   Panay, Nick ^b   Hamoda, Haitham ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Estrogen; Hormone replacement therapy; Menopause; Osteoporosis; Vasomotor symptoms

Indexed keywords

CONJUGATED ESTROGEN PLUS NORGESTREL; DYDROGESTERONE PLUS ESTRADIOL; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTRADIOL VALERATE PLUS NORETHISTERONE; ETHINYLESTRADIOL; MICRONISED PROGESTERONE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; TESTOSTERONE; TIBOLONE; UNCLASSIFIED DRUG; GONADOTROPIN;

ARTICLE; BONE DENSITOMETRY; BRITISH MENOPAUSE SOCIETY; CROSS-SECTIONAL STUDY; FEMALE FERTILITY; FOLLOW UP; HEALTH CARE PERSONNEL; HEALTH PERSONNEL ATTITUDE; HEALTH SURVEY; HORMONE SUBSTITUTION; HUMAN; MEDICAL PRACTICE; MEDICAL SOCIETY; MENOPAUSE; OSTEOPOROSIS; PREMATURE OVARIAN FAILURE; QUESTIONNAIRE; ADULT; CLINICAL PRACTICE; EARLY MENOPAUSE; ESTROGEN THERAPY; FEMALE; GYNECOLOGY; PRIMARY OVARIAN INSUFFICIENCY; STANDARDS; STATISTICS AND NUMERICAL DATA; UNITED KINGDOM; WOMEN'S HEALTH;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; GONADOTROPINS; GREAT BRITAIN; GYNECOLOGY; HUMANS; MENOPAUSE, PREMATURE; PHYSICIAN'S PRACTICE PATTERNS; POPULATION SURVEILLANCE; PRIMARY OVARIAN INSUFFICIENCY; QUESTIONNAIRES; WOMEN'S HEALTH;

EID: 84925118955     PISSN: 20533691     EISSN: 20533705     Source Type: Journal    
DOI: 10.1177/2053369114540883     Document Type: Article

References (28)

1. Albright F, Smith PH and Fraser R. A syndrome characterized by primary ovarian insufficiency and decreased stature. Am J Med Sci 1942; 204: 625.
2. Panay N and Kalu E. Management of premature ovarian failure. Best Pract Res Clin Obstet Gynaecol 2009; 23: 129-140.
3. Cartwright B, Robinson J and Rymer J. Treatment of premature ovarian failure trial: description of an ongoing clinical trial. Menopause Int 2010; 16: 18-22.
4. Shelling AN. Premature ovarian failure. Reproduction 2010; 140: 633-641.
5. Cartwright B, Holloway D, Grace J, et al. A service evaluation of women attending the menopause/premature ovarian failure clinic of a tertiary referral centre. J Obstet Gynaecol 2012; 32: 357-361.
6. Pitkin J, Rees MCP, Gray S, et al. Writing Group for the British Menopause Society Council: British Menopause Society Council Consensus Statement Management of premature menopause. Menopause Int 2007; 13: 44-45.
7. Fauser BCJM, Laven JSE, Tarlatzis BC, et al. Sex steroid hormones and reproductive disorders: impact on women’s health. Reprod Sci 2011; 18: 702-712.
8. Singer D, Mann E, Hunter MS, et al. The silent grief: psychosocial aspects of premature ovarian failure. Climacteric 2011; 14: 428-437.
9. Kalu E and Panay N. Spontaneous premature ovarian failure: management challenges. Gynecol Endocrinol 2008; 24: 273-279.
10. Nelson LM. Primary ovarian insufficiency. N Engl J Med 2009; 360: 606-614.
11. De Vos M, Devroey P and Fauser BCJM. Primary ovarian insufficiency. Lancet 2010; 376: 911-921.
12. Gallagher JC. Effect of early menopause on bone mineral density and fractures. Menopause 2007; 14: 567-571.
13. Panay N, Hamoda H, Arya R, et al. The 2013 British Menopause Society & Women’s Health Concern recommendations on hormone replacement therapy. Menopause Int 2013; 19: 59-68.
14. De Villiers TJ, Pines A, Panay N, et al. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 2013; 16: 316-337.
15. Schmidt P. The 2012 Hormone Therapy Position Statement of the North American Menopause Society. Menopause 2012; 19: 257-271.
16. Vega EM, Egea MA and Mautalen CA. Influence of the menopausal age on the severity of osteoporosis in women with vertebral fractures. Maturitas 1994; 19: 117-124.
17. Wassertheil-Smoller S, et al. Effect of estrogen plus progestin on stroke in postmenopausal women. The women’s health initiative: a randomised trial. J Am Med Assoc 2003; 289: 2673-2684.
18. The Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The women’s health initiative randomized controlled trial. J Am Med Assoc 2004; 291: 1701-1712.
19. Rocca WA, Grossardt BR, Miller VM, et al. Premature menopause or early menopause and risk of ischemicstroke. Menopause 2012; 9: 272-277.
20. Renoux C, Dell’Aniello S, Garbe E, et al. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ 2010; 340: 1-7.
21. Renoux C, Dell’Aniello S and Suissa S. Hormone replacement therapy and the risk of venous thromboembolism: a population-based study. J Thromb Haemostasis 2010; 8: 979-986.
22. Simon JA. What’s new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone. Climacteric 2012; 15(Suppl 1): 3-10.
23. Mueck AO. Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone. Climacteric 2012; 15(Suppl 1): 11-17.
24. Mittal M, et al. A randomised controlled trial comparing the effects of micronized progesterone to medroxyprogesterone acetate on cardiovascular health, lipid metabolism and the coagulation cascade in women with premature ovarian insufficiency: study protocol and review of the literature. Menopause Int 2013; 19: 127-132.
25. Panay N, Lazaridis A and Maclaran K. Investigating UK and international practices for managing premature ovarian failure. Maturitas 2012; 71: S25.
26. Rebar RW and Connolly HV. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Sterility 1990; 53: 804-810.
27. Min J, YiQi Y and He Feng H. An update on primary ovarian insufficiency. Sci China, Life Sci 2012; 55: 677-686.
28. Goswami D and Conway GS. Premature ovarian failure. Hum Reprod Update 2005; 11: 391-410.